Compass Therapeutics, Inc. (CMPX) vs Foghorn Therapeutics Inc. (FHTX)

Compass Therapeutics, Inc. and Foghorn Therapeutics Inc. are both Biotechnology companies. Compass Therapeutics, Inc. and Foghorn Therapeutics Inc. are of similar size ($213.8M and $205.3M). Compass Therapeutics, Inc. has the higher net margin (0.00% vs −175.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Foghorn Therapeutics Inc. leads on 6 and Compass Therapeutics, Inc. on 5.

Valuation

Metric CMPX FHTX Biotechnology median
P/E n/m n/m 7.88
P/S n/m 6.73 11.47
P/B 1.27 n/m 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m 3.22 10.73
Earnings yield (35.40%) (28.00%) (28.84%)
Free cash flow yield (26.71%) (34.11%) (23.03%)

Profitability

Metric CMPX FHTX Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (198.04%) 0.00%
Net margin 0.00% (175.78%) 0.00%
Free cash flow margin 0.00% (229.49%) 0.00%
Return on equity (56.66%) 81.90% (57.72%)
Return on assets (47.87%) (30.06%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX FHTX Biotechnology median
Revenue growth (TTM) — 51.98% 5.64%
EPS growth (last fiscal year) (16.67%) 25.32% —
Revenue growth, 5-year CAGR — 135.14% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX FHTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 3.36 4.73
Net debt to EBITDA 2.86 1.88 0.96

Dividend

Metric CMPX FHTX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric CMPX FHTX Biotechnology median
Market cap 205.30m 213.79m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack